Mr. Shaun Flanagan:

I also have to be clear that if additional funding is required, there is a process we have to go through. That normally involves an assessment process. We have tried to put the negotiation in front of that assessment process to expedite this and get to a solution as quickly as possible.

I should have acknowledged at the start that I understand absolutely that people would be very upset that they do not have access to the drug,. That is not where any of us would want to be. We would want to have been in a position where we could have provided access quickly, as we did for all the other licence amendments as they came along.